-33%The "Triple-Threat" Metabolic Catalyst
Sold by Bio Compounds UK
Only a few items left
In the evolution of metabolic science, we have moved from single-pathway signalling to a total-system overhaul.
This research compound represents the absolute pinnacle of current incretin-mimetic technology. While previous generations focused on one or two receptors, this Triple Hormone Receptor Agonist targets three distinct pathways simultaneously: GLP-1 (Glucagon-like peptide-1), GIP (Glucose-dependent insulinotropic polypeptide), and the Glucagon receptor (GCGR). This trifecta is currently being studied for its unprecedented ability to accelerate metabolic rate and fat mobilization while maintaining strict glucose control.
The Science of "Thermogenic Synergy"
By adding the Glucagon receptor to the traditional GLP-1/GIP pairing, this molecule offers a unique research window into "energy expenditure" rather than just appetite suppression.
Key Research Benchmarks:
-
Triple-Action Signalling: While GLP-1 and GIP optimize insulin secretion and satiety, the addition of the Glucagon agonist signals the liver to increase energy expenditure and lipolysis (fat breakdown).
-
Unmatched Mass Reduction Research: In ongoing clinical observations, this specific triple-pathway approach has demonstrated a potential for weight reduction that significantly exceeds that of previous dual-agonists.
-
Mitochondrial Efficiency: Studied for its role in "browning" white adipose tissue, potentially turning stored energy into heat and increasing basal metabolic rate (BMR).
-
Liver Health & NAFLD Research: Beyond weight, this molecule is a primary subject in studies regarding the reduction of hepatic fat content and the reversal of fatty liver markers.
The Midland Peptides Advantage
"The Next Generation of Metabolic Sovereignty." This compound is supplied in a high-purity lyophilized state, ensuring the complex molecular structure remains stable for precise laboratory quantification. For researchers investigating the absolute limit of human metabolic potential, this triple agonist is the definitive tool.
Total Saturation. Maximum Oxidation. Metabolic Mastery.
⚠️ Research Use Only Disclaimer
This product is strictly for laboratory research purposes only. This compound is currently in investigational phases and is not approved by the FDA, MHRA, or any other regulatory body for human consumption, weight loss, or the treatment of obesity. Use of this product in a clinical or human setting is strictly prohibited. The purchaser assumes all responsibility for the handling and application of this material.
